Positive steps but still many challenges - the ...
July 4, 2022
Broughton's Chief Executive Officer, Chris Allen summarizes the highlights from Global Forum on Nicotine (GFN).
Broughton shares the highlights from Next ...
June 24, 2022
Broughton's Chief Commercial Officer, Andy Mooney summarizes the highlights from Next Generation Nicotine Delivery Conference USA.
FDA PMTA 90-day deficiency letters – what next?
June 1, 2021
Broughton Head of Scientific Affairs, Paul Hardman outlines factors that can lead to data gaps in Premarket Tobacco Product Applications ...
Broughton is delighted to sponsor and present at ...
April 13, 2021
Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary to present the future challenges of the ENDS regulatory battleground and the ...
Dr Nveed Chaudhary joins Broughton and discusses ...
February 19, 2021
Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary discusses business growth and Broughton’s plans to extend its service portfolio ...
Skin sensitization in silico protocol
July 17, 2020
In silico methods for the prediction of toxicity are becoming more widely used in the field of toxicology.
A Guide To Toxicology Risk Assessments
June 11, 2020
Broughton has produced an infographic to explain the process for toxicology risk assessments for Electronic Nicotine Delivery Systems ...
